Literature DB >> 11897422

Prediction of plasma concentration-time curve of orally administered theophylline based on a scintigraphic monitoring of gastrointestinal transit in human volunteers.

Shunji Haruta1, Keiichi Kawai, Ryuichi Nishii, Seishi Jinnouchi, Ken ichi Ogawara, Kazutaka Higaki, Shozo Tamura, Kazuhiko Arimori, Toshikiro Kimura.   

Abstract

The plasma concentration-time profile of theophylline after oral administration in human volunteers was predicted using the individual gastrointestinal (GI) transit data monitored by a gamma scintigraphic technique. Theophylline was administered as aminophylline under fasted and fed condition, along with 99mTc-labeled diethylenetriamine-pentaacetic acid (DTPA), an unabsorbable marker to evaluate the GI transit by a gamma scintigraphic technique. Two healthy male volunteers participated under fasted and fed conditions in a crossover study. The GI transit was evaluated by dividing the GI tract to four segments, stomach, jejunum, ileum and cecum/colon. Under the fed condition, the GI transit pattern for each segment was confirmed to alter considerably, causing a delay in the gastric emptying mainly. Further, the plasma concentration curves of theophylline after oral administration were predicted using the GI-Transit-Absorption Model on the basis of individual GI transit parameters calculated by the fitting of the observed data to the GI-Transit Kinetic Model. The absorption rate constant in each segment and the pharmacokinetic parameters after intravenous administration used for the prediction were the values extrapolated from the data in rats and the ones normalized from the values in literatures, respectively. The plasma concentration-time curves for theophylline were well predicted using obtained individual GI transit parameters. The analysis using this method could estimate the variable absorption behavior governed by the GI transit in detail.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897422     DOI: 10.1016/s0378-5173(01)00942-5

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  5 in total

1.  Quantitative evaluation of PEPT1 contribution to oral absorption of cephalexin in rats.

Authors:  Takanori Hironaka; Shota Itokawa; Ken-ichi Ogawara; Kazutaka Higaki; Toshikiro Kimura
Journal:  Pharm Res       Date:  2008-09-11       Impact factor: 4.200

2.  In silico model as a tool for interpretation of intestinal infection studies.

Authors:  Peter de Jong; Marc M M Vissers; Roelof van der Meer; Ingeborg M J Bovee-Oudenhoven
Journal:  Appl Environ Microbiol       Date:  2006-11-22       Impact factor: 4.792

3.  Efficient Evaluation of In Vivo Performance in Human for Generic Formulation by Novel Dissolution-Absorption Prediction (DAP) Workflow.

Authors:  Motoki Onishi; Kozo Tagawa; Maiko Jiko; Kayo Koike; Masato Maruyama; Hidetoshi Hashizume; Kazuhide Imagaki; Kazutaka Higaki
Journal:  Pharm Res       Date:  2022-07-14       Impact factor: 4.580

4.  Effect of Excessive Serotonin on Pharmacokinetics of Cephalexin after Oral Administration: Studies with Serotonin-Excessive Model Rats.

Authors:  Shun Nakashima; Takeharu Iwamoto; Masashi Takanashi; Ken-Ichi Ogawara; Masato Maruyama; Kazutaka Higaki
Journal:  Pharm Res       Date:  2022-07-08       Impact factor: 4.580

5.  Models of antimicrobial pressure on intestinal bacteria of the treated host populations.

Authors:  V V Volkova; C L Cazer; Y T Gröhn
Journal:  Epidemiol Infect       Date:  2017-05-02       Impact factor: 4.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.